New Products to be Showcased at CHI’s 21st International Molecular Med TRI-CON February 9-14

SAN FRANCISCO - Feb. 6, 2014 - PRLog -- The 2014 event includes the New Product Showcase, where companies will showcase their new products to event delegates.

http://www.triconference.com/

New Products Include:
Acumenta Biotech          Booth 4
www.acumenta.com
Literature Lab - Acumenta Biotech announces Literature Lab™ with new Visualization Extensions for pathway analysis and biological interpretation of gene sets.  Clustering analysis and heatmaps accelerate understanding of complex data sets.  See us in booth 4.

Maverix Biomics, Inc.          Booth 532
www.maverixbio.com
The Maverix Analytic Platform - Maverix provides researchers with a cloud-based platform to manage, analyze, and visualize genomic data, build Communities of Discovery, and place new data in context with the latest public data from human, plant, animal, and microbial organisms.

Metabolon          Booth 437
www.metabolon.com
Quantose IR™ laboratory developed clinical test - Metabolon’s Quantose IR™ laboratory developed clinical test, conducted in a CAP-accredited facility, is available as a development tool to identify responders/non-responders in cardiovascular/metabolic disease indications. In a 3 year RISC study, Quantose IR biomarkers independently and significantly predicts worsening glycemic control, and outperformed traditional risk measures such as fasting insulin, fasting glucose, BMI, and HOMA-IR in predicting insulin resistance and progression to impaired glucose tolerance. Biomarker discovery and development services, enabled through metabolomic analysis, are also available. www.metabolon.com 919.572.1711.

OpenEye Scientific Software          Booth 426
www.eyesopen.com
pKa Prospector  - pKa Prospector enables users to identify the best data on the likely protonation state of novel molecules through rapid access to a comprehensive database of well-curated high-quality experimental pKa measurements.

Singulex          Booth 509
www.singulex.com
Erenna® Immunoassay Development Kits - Singulex offers new assay development kits for their innovative Erenna® Immunoassay System. Develop your own immunoassays with ease, and take advantage of the benefits of Single Molecule Counting (SMC™) technology.

SRI International          Booth 623
www.sri.com
FASTcell™  - SRI's FASTcell™ technology delivers superior enumeration and characterization of CTCs.  Fiber-optic Array Scanning Technology is used in a non-enrichment approach for unbiased detection, imaging and isolation of individual CTCs from blood.

SurModics          Booth 318
www.surmodics.com
StabilZyme® Protein-Free Stabilizer - SurModics NEW StabilZyme® Protein-Free Stabilizer offers greater retained activity and in a protein-free formulation, ensuring dependable results without the risk of unwanted interference.  Stabilize biomolecule activity without protein!

Thomson Reuters          Booth 500
www.thomsonreuters.com
Cortellis for Clinical Trials Intelligence - Cortellis Clinical Trials Intelligence, the most powerful resource to accelerate clinical trial development decisions and portfolio strategy.  Provides coverage of over 145,000 clinical trials for biomarkers, devices, biologics and drugs.

TwistDx
www.twistdx.com
Twirla™- portable mixing incubator - Twirla™ prepares RPA reactions for end-point measurement. The Twirla™ is small, light weight, and has multiple power options and thus the perfect solution for field-use RPA.

Viator Technologies,Inc.       Booth 716
www.viatortech.com
VTI CTCS 3.0™ - Viator Technologies Inc. introduces the VTI CTCS 3.0™, Circulating Tumor Cell Detection and Capture System. The CTCS 3.0™ uses photoacoustic technology to rapidly isolate CTCs from blood for further analyses.

Viracor IBT Laboratories       Booth 214
www.viracoribt.com
Custom Assay Development, transfer and validation services - Viracor-IBT offers custom assay development, transfer and validation services with expertise in biologics, molecular, immune-response & immunologic based testing.  Streamlined processes provide more options and flexibility to meet study-specific needs.

About Molecular Med TRI-CON
The 21st International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology.  Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, 20 short courses, and 15 conference programs.  For the first time in over 10 years we’re bringing back a dedicated conference on sequencing. As many will recall this event’s infancy was heavily devoted to the Human Genome Project and we are excited to reintroduce sequencing to this event.

For over 20 years, Tri-Conference attendees gained insight and knowledge by attending, knowledge that they were able to take with them, and have an immediate impact on their research.  Plan to attend this year’s Tri-Conference where you can be part of driving change and working towards shaping the future of medicine.

http://www.triconference.com/